Trials / Completed
CompletedNCT03562715
microRNAs Role in Pre-eclampsia Diagnosis
Role of Mesenchymal Stem Cells Exosomes Derived microRNAs; miR-136, miR-494 and miR-495 in Pre-eclampsia Diagnosis and Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 23 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Pre-eclampsia is one of the most threatening pregnancy complications. So far neither a secure, competent therapy for PE nor effective biomarkers for a premature discovery has been achieved.The aim of our study was to identify miRNAs 136, 494 and 495 genes expression in exosomes of peripheral blood compared to umbilical cord mesenchymal stem cells conditioned media released exososomes in patients with PE, as valuable markers for PE early prediction.
Conditions
Timeline
- Start date
- 2016-11-28
- Primary completion
- 2017-06-15
- Completion
- 2017-12-25
- First posted
- 2018-06-19
- Last updated
- 2018-06-19
Source: ClinicalTrials.gov record NCT03562715. Inclusion in this directory is not an endorsement.